DrugPatentWatch Database Preview

Ivosidenib - Generic Drug Details

« Back to Dashboard

What are the generic sources for ivosidenib and what is the scope of ivosidenib patent protection?

Ivosidenib is the generic ingredient in one branded drug marketed by Agios Pharms Inc and is included in one NDA. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Ivosidenib has forty-three patent family members in twenty-three countries.

One supplier is listed for this compound.

Summary for ivosidenib

International Patents:	43
US Patents:	3
Tradenames:	1
Applicants:	1
NDAs:	1
Suppliers / Packagers:	1
Bulk Api Vendors:	25
Clinical Trials:	5
Patent Applications:	19
DailyMed Link:	ivosidenib at DailyMed

Synonyms for ivosidenib

(2S)-N-[(1S)-1-(2-chlorophenyl)-2-[(3,3-difluorocyclobutyl)amino]-2-oxoethyl]-1-(4-cyanopyridin-2-yl)-N-(5-fluoropyridin-3-yl)-5-oxopyrrolidine-2-carboxamide

(S)-N-((S)-1-(2-chlorophenyl)-2-((3,3-difluorocyclobutyl)amino)-2-oxoethyl)-1-(4-cyanopyridin-2-yl)-N-(5-fluoropyridin-3-yl)-5-oxopyrrolidine-2-carboxamide

(S)-N-((S)-1-(2-chlorophenyl)-2-(3,3-difluorocyclobutylamino)-2-oxoethyl)-1-(4-cyanopyridin-2-yl)-N-

1448347-49-6

1448347-49-6 (Ivosidenib)

AG-120

AG120

AKOS028113340

AS-35058

CHEMBL3989958

CS-5122

EX-A992

Glycinamide, 1-(4-cyano-2-pyridinyl)-5-oxo-L-prolyl-2-(2-chlorophenyl)-N-(3,3-difluorocyclobutyl)-N2-(5-fluoro-3-pyridinyl)-, (2S)-

GTPL9217

HY-18767

Ivosidenib [INN]

Ivosidenib [USAN]

Ivosidenib [WHO-DD]

MolPort-044-560-317

Q2PCN8MAM6

RG120

s8206

SCHEMBL15122512

UNII-Q2PCN8MAM6

ZINC205136523

US Patents and Regulatory Information for ivosidenib

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Agios Pharms Inc	TIBSOVO	ivosidenib	TABLET;ORAL	211192-001	Jul 20, 2018		RX	Yes	Yes			Y
Agios Pharms Inc	TIBSOVO	ivosidenib	TABLET;ORAL	211192-001	Jul 20, 2018		RX	Yes	Yes
Agios Pharms Inc	TIBSOVO	ivosidenib	TABLET;ORAL	211192-001	Jul 20, 2018		RX	Yes	Yes			Y	Y
Agios Pharms Inc	TIBSOVO	ivosidenib	TABLET;ORAL	211192-001	Jul 20, 2018		RX	Yes	Yes

International Patents for ivosidenib

Country	Document Number	Estimated Expiration
Eurasian Patent Organization	201691845
European Patent Office	3116492
Eurasian Patent Organization	201692271
Japan	2017101067